先駆け審査指定制度対象品目の募集 against K.K. Heriosu
株式会社 ヘリオス (薬事法)
薬事法Ministry of Health, Labour and WelfareOctober 5, 2017
Action summary
- Company
- K.K. HeriosuRomanizedOriginal: 株式会社 ヘリオス
- Governing law
- 薬事法薬事法
- Action type
- 先駆け審査指定制度対象品目の募集先駆け審査指定制度対象品目の募集
- Action date
- October 5, 2017
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Machine-translated summary — verify against original
Human (same species) adult bone marrow-derived pluripotent precursor cells for acute phase cerebral infarction (18 to 36 hours after onset)
Show original Japanese text
ヒト（同種）成人骨髄由来多能性前駆細胞 脳梗塞急性期（発症後18～36時間）
Source
Original Ministry of Health, Labour and Welfare announcement (in Japanese)The original Japanese disclosure is the authoritative record.
Watch this company
Get an email when K.K. Heriosu has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.